ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced the opening of new offices in Prague, Kiev and Bucharest as it continues expansion of its clinical research activity in the Central and Eastern Europe region.
The healthcare environment in the region, with its large homogenous patient populations, competitive approval timelines and a network of highly qualified investigators, offered great opportunities and facilities for drug development, according to Alan Morgan, president ICON Clinical Research Europe. ICON’s new facilities are strategically located near leading teaching hospitals and national clinical research sites, providing access to investigators and patient groups. The company already has offices in Russia (Moscow and Novosibirsk), Latvia, Lithuania, Poland and Hungary. (polishmarket.com)